Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Heart Test Laboratories, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.31 | -$2.31 | -$2.31 |
| Q2 2025 | 2 | -$2.51 | -$1.78 | -$2.15 |
| Q3 2025 | 1 | -$2.01 | -$2.01 | -$2.01 |
| Q4 2025 | 1 | -$1.87 | -$1.87 | -$1.87 |
| Q1 2026 | 1 | -$1.81 | -$1.81 | -$1.81 |
| Q2 2026 | 1 | -$1.69 | -$1.69 | -$1.69 |
Heart Test Laboratories, Inc. Earnings Date And Information
Heart Test Laboratories, Inc. last posted its earnings results on Thursday, March 13th, 2025. The company reported $-2.57 earnings per share for the quarter, missing analysts' consensus estimates of $-2.53 by $0.04. The company had revenue of 0 for the quarter and had revenue of 18.60 K for the year. Heart Test Laboratories, Inc. has generated $-19 earnings per share over the last year ($-18.74 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Heart Test Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 2nd, 2025 based on prior year's report dates.
Heart Test Laboratories, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/13/2025 | Q3 2025 | -$2.53 | -$2,572.16 | -2569.63 | $550.00 K | $0 |
| 12/16/2024 | Q2 2025 | -$2.30 | -$2.27 | 0.03 | $400.00 K | $0 |
| 09/12/2024 | Q1 2025 | -$2.46 | -$2.64 | -0.18 | $200.00 K | $0 |
| 07/29/2024 | Q4 2024 | -$3.50 | -$2.73 | 0.77 | $50.00 K | $0 |
| 03/14/2024 | Q3 2024 | -$0.06 | -$3.06 | -3 | N/A | $14.70 K |
| 12/14/2023 | Q2 2024 | -$0.12 | -$15.98 | -15.86 | N/A | $3.90 K |
| 09/14/2023 | Q1 2024 | -$0.14 | -$13.23 | -13.09 | N/A | $0 |
| 07/18/2023 | Q4 2023 | N/A | -$16.47 | N/A | N/A | $5.14 M |
| 03/16/2023 | Q3 2023 | $0.16 | -$16.47 | -16.63 | $1.00 K | $1.95 K |
| 12/15/2022 | Q2 2023 | -$0.33 | -$22.39 | -22.06 | N/A | $0 |
| 09/12/2022 | Q1 2023 | -$28.00 | -$30.55 | -2.55 | $3.00 K | $3.20 K |
| 07/29/2022 | Q4 2022 | N/A | -$64.04 | N/A | N/A | $4.15 K |
| 01/31/2022 | Q3 2022 | N/A | -$37.27 | N/A | N/A | $2.74 K |
| 10/30/2021 | Q2 2022 | N/A | -$31.23 | N/A | N/A | $0 |
| 07/31/2021 | Q1 2022 | N/A | -$15.14 | N/A | N/A | $7.48 K |
| 04/29/2021 | Q4 2021 | N/A | -$25.70 | N/A | N/A | $14.95 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Heart Test Laboratories, Inc. Earnings: FAQ's
Heart Test Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 2nd, 2025 based offlast year's report dates.
The conference call for Heart Test Laboratories, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Heart Test Laboratories, Inc.'s latest earnings report can be read online.
Heart Test Laboratories, Inc. (:HSCS) has a recorded annual revenue of $18.60 K.
Heart Test Laboratories, Inc. (:HSCS) has a recorded net income of $-6,605,208.Heart Test Laboratories, Inc. has generated $-18.74 earnings per share over the last four quarters.
Heart Test Laboratories, Inc. (:HSCS) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.